---
$id: https://graph.org.ai/products/commodity/51361940
$type: Product
source: UNSPSC
code: "51361940"
title: "Secobarbital sodium"
class: "51361900"
classTitle: "Hypnotic barbiturates"
family: "51360000"
familyTitle: "Hypnotics"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Secobarbital sodium

**UNSPSC Code**: 51361940
**Class**: [Hypnotic barbiturates](Hypnotic barbiturates.mdx)
**Family**: [Hypnotics](../Hypnotics.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes a barbiturate with the molecular formula C12H17N2O3.Na, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier XBP604F6UM, chemically known as 2,4,6 (1h,3h,5h)-pyrimidinetrione, 5-(1-methylbutyl)-5-(2-propenyl)-, monosodium salt but more generally known as secobarbital sodium, which bears US NIH Compound Identifier 5193. European Medicines Agency schedules Secobarbital sodium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04344MIG. Most nations, for tariff and trade purposes, schedule secobarbital sodium under HS 29335300 and SITC 51576. As of Q4 2014, SECOBARBITAL SODIUM remains US FDA's Preferred Term for this commodity. Secobarbital sodium bears US NLM identifiers UMLS ID C0304359 and NCI Concept Code C66530. SMILES: CCCC(C)C1(C(=O)NC(=O)[N-]C1=O)CC=C.[NA+].

